Mark Rothera is the founder of Viracta Therapeutics. Viracta Therapeutics has raised $83M, latest Series D $65M (2019). Biotech · Cardiff, CA.
Mark Rothera is the founder of Viracta Therapeutics. Viracta Therapeutics operates in Biotech and is based in Cardiff, CA. Viracta Therapeutics has raised $83M, latest Series D $65M (2019). Backers on record include Walid Gardezi, Serrado Capital.
This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in Cardiff — who backed them, at what stage, and how much they raised.
Full founder directory · Investor directory · Company funding database · Fundraising library